Showing results (371-380 of 414) with videos related to
Sort By:
Pageof 42
The New England Journal of Medicine|January 20, 2012
Preliminary study of two antiviral agents for hepatitis C genotype 1Anna S Lok, David F Gardiner, Eric Lawitz, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 12, 2020
Coronavirus Disease 2019 (COVID-19) Clinical Trial Oversight at a Major Academic Medical Center: Approach of Michigan MedicineKayte Spector-Bagdady, Peter D R Higgins, Keith D Aaronson, et al.Hepatology (Baltimore, Md.)|August 3, 2020
Clinical Research in Hepatology in the COVID-19 Pandemic and Post-Pandemic Era: Challenges and the Need for InnovationElizabeth C Verna, Marina Serper, Jaime Chu, et al.Journal of Hepatology|May 24, 2016
Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis BAnna S Lok, Calvin Q Pan, Steven-Huy B Han, et al.The American Journal of Gastroenterology|October 29, 2019
Phase Transition Is Infrequent Among North American Adults With e-Antigen-Negative Chronic Hepatitis B and Low-Level ViremiaKali Zhou, Abdus S Wahed, Stewart Cooper, et al.Hepatology Communications|May 3, 2024
PHES scores have limited impact on the risk of overt HE in patients with minimal HESimon Johannes Gairing, Chiara Mangini, Lisa Zarantonello, et al.Hepatology Communications|February 23, 2026
Validation of longitudinal biomarker screening algorithms for HCC detection in patients with cirrhosisAmit G Singal, Qingchun Jin, Jorge Marrero, et al.Journal of Hepatology|April 4, 2020
DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohortElizabeth C Verna, Giuseppe Morelli, Norah A Terrault, et al.Journal of Hepatology|May 17, 2019
Patient-reported symptoms during and after direct-acting antiviral therapies for chronic hepatitis C: The PROP UP studyDonna M Evon, Souvik Sarkar, Jipcy Amador, et al.Gastroenterology|October 14, 2008
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver diseaseAnna S Lok, Leonard B Seeff, Timothy R Morgan, et al.Pageof 42